Trials / Terminated
TerminatedNCT00747812
Study of Occipital Nerve Stimulation for Drug Refractory Migraine
A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Occipital Nerve Stimulation for Drug Refractory Migraine
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of an implantable device to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Precision | Implantable Neurostimulator |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2008-11-01
- Completion
- 2012-05-01
- First posted
- 2008-09-05
- Last updated
- 2020-11-27
- Results posted
- 2012-08-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00747812. Inclusion in this directory is not an endorsement.